| answer text |
<p>In future, NHS England will seek clinical advice on issues relating to gastrointestinal
and liver disease from a variety of sources. This will include experts at Public Health
England (PHE) for issues which are alcohol related, the National Clinical Director
for Obesity and Diabetes for issues relating to obesity induced fatty liver disease
as well as through the Clinical Reference Group for hepatitis C and the medical Royal
Colleges.</p><p> </p><p>Information on liver and gastrointestinal (GI) diseases is
also available from the National Institute for Health and Care Excellence, PHE Atlases
of variation, relevant national audits and regular clinical communication between
the national Medical Director, his senior team and the relevant Royal Colleges and
specialist societies and with senior professionals.</p><p> </p><p>NHS England continues
to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways
for GI disease are reviewed and clinical advice is taken regarding policy developments
to address the current and projected requirement in capacity. The relevant specialist
societies are key members of this group. NHS England also supports the national Cancer
Implementation Programme on behalf of the arm’s length bodies, which includes workstreams
on early diagnosis, and on living with and beyond cancer, both of which are addressing
many issues that affect patients with GI cancers.</p><p> </p><p>Health Education England
will continue to ensure that they engage with employers to forecast how many gastroenterologists
they require year on year. The process for making decisions relating to medical training
numbers is currently being refined. Medical speciality training post numbers will
be reviewed in greater depth with a range of stakeholders on a rolling programme;
approximately every two years. Gastroenterology is expected to be reviewed this winter.</p>
|
|
